Research Article
The Clinical Characteristics and Prognostic Nomogram for Head and Neck Cancer Patients with Bone Metastasis
Table 1
Demographic and clinical characteristics of HNSCC patients with bone metastases.
| Variables | Training cohort | Validation cohort | N = 230 | N = 96 | n | % | n | % |
| Age | | | | | <47 | 34 | 14.8 | 14 | 14.6 | 47–72 | 157 | 68.3 | 63 | 65.6 | >72 | 39 | 17.0 | 19 | 19.8 | >66 | 733 | | | |
| Race | | | | | Black | 44 | 19.1 | 25 | 26.0 | Other | 30 | 13.1 | 14 | 14.6 | White | 156 | 67.8 | 57 | 59.4 |
| Sex | | | | | Female | 53 | 23.0 | 26 | 27.1 | Male | 177 | 77.0 | 70 | 72.9 |
| Primary site | | | | | Oropharynx | 74 | 32.2 | 26 | 27.1 | Hypopharynx | 7 | 3.0 | 7 | 7.3 | Larynx | 28 | 12.2 | 7 | 7.3 | Nasopharynx | 59 | 25.7 | 24 | 25.0 | Oral cavity | 62 | 27.0 | 32 | 33.3 |
| Histological types | | | | | Others | 59 | 25.7 | 25 | 26.1 | Squamous cell carcinoma | 171 | 74.3 | 71 | 73.9 |
| Grade | | | | | I | 6 | 2.6 | 3 | 3.1 | II | 60 | 26.1 | 25 | 26.0 | III | 126 | 54.8 | 51 | 53.1 | IV | 38 | 16.5 | 17 | 17.7 |
| T stage | | | | | T1 | 35 | 15.2 | 10 | 10.4 | T2 | 41 | 17.8 | 20 | 20.8 | T3 | 52 | 22.6 | 24 | 25.0 | T4 | 102 | 44.3 | 42 | 43.8 |
| N stage | | | | | N0 | 34 | 14.8 | 14 | 14.6 | N1 | 50 | 21.7 | 25 | 26.0 | N2 | 126 | 54.8 | 44 | 45.8 | N3 | 20 | 8.7 | 13 | 13.6 |
| Surgery | | | | | No | 187 | 81.3 | 76 | 79.2 | Yes | 43 | 18.7 | 20 | 20.8 |
| Chemotherapy | | | | | No | 83 | 36.1 | 32 | 33.3 | Yes | 147 | 63.9 | 64 | 66.7 |
| Radiotherapy | | | | | No | 105 | 45.7 | 35 | 36.5 | Yes | 125 | 54.3 | 61 | 63.5 |
| Liver metastasis | | | | | No | 184 | 80.0 | 82 | 85.4 | Yes | 46 | 20.0 | 14 | 14.6 |
| Brain metastasis | | | | | No | 216 | 93.9 | 92 | 95.8 | Yes | 14 | 6.1 | 4 | 4.2 |
| Lung metastasis | | | | | No | 161 | 70.0 | 66 | 68.8 | Yes | 69 | 30.0 | 30 | 31.2 |
| Insurance status | | | | | No | 25 | 10.9 | 13 | 13.5 | Yes | 205 | 89.1 | 83 | 86.5 |
| Marital | | | | | No | 120 | 52.2 | 49 | 51.0 | Yes | 110 | 47.8 | 47 | 49.0 |
|
|